Conservative management of young women with endometrial carcinoma or complex atypical hyperplasia: Report of three cases and literature review

European Journal of Gynaecological Oncology

Volumn 32, Issue 6, 2011, Pages 695-698

  Karimi Zarchi, M ^a   Mousavi, A S ^b   Behtash, N ^b   Chiti, Z ^a   Bokaie, M ^a  

^a SHAHID SADOUGHI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Conservative management; Endometrial cancer; Infertility

Indexed keywords

DYDROGESTERONE; MEDROXYPROGESTERONE ACETATE; MEGESTROL ACETATE; PROGESTERONE;

ADULT; ARTICLE; CANCER GRADING; CANCER HORMONE THERAPY; CANCER PATIENT; CANCER REGRESSION; CANCER STAGING; CASE REPORT; CONSERVATIVE TREATMENT; CONTRAST ENHANCEMENT; CURETTAGE; DRUG MEGADOSE; EARLY CANCER; ENDOMETRIUM CARCINOMA; ENDOMETRIUM HYPERPLASIA; FEMALE; FEMALE FERTILITY; HISTORY; HUMAN; LAPAROSCOPY; LYMPH NODE; NUCLEAR MAGNETIC RESONANCE IMAGING; PERITONEUM; PHYSICAL EXAMINATION; RISK BENEFIT ANALYSIS; UNSPECIFIED SIDE EFFECT;

ADENOCARCINOMA; ADULT; ENDOMETRIAL HYPERPLASIA; ENDOMETRIAL NEOPLASMS; FEMALE; FERTILITY PRESERVATION; HUMANS; PRECANCEROUS CONDITIONS; YOUNG ADULT;

EID: 84855515866     PISSN: 03922936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. rd edition, Philadelphia, PA: Lippincott Williams and Wilkins, 2000, 981.
2. Gallup D.G., Stock R.J.: "Adenocarcinoma of the endometrium in women 40 years of age or younger". Obstet. Gynecol., 1984, 64, 417.
3. Kim Y.B., Holschneider C.H., Ghosh K., Nieberg R.K., Montz F.J.: "Progestin alone as primary treatment of endometrial carcinoma in premenopausal women. Report of seven cases and review of the literature". Cancer, 1997, 79, 320.
4. Bokhman J.V., Chepick O.F., Volkova A.T., Vishnevsky A.S.: "Can primary endometrial carcinoma Stage I be cured without surgery and radiation therapy?". Gynecol. Oncol., 1985, 20, 139.
5. Farhi D.C., Nosanchuk J., Silverberg S.G.: "Endometrial adenocarcinoma in women under 25 years of age". Gynecol. Obstet., 1986, 68, 741.
6. Aamio M., Sankila R., Pukkala E.: "Cancer risk in mutation carriers of DNA-mismatch-repair genes". Int. J. Cancer, 1999, 81, 214.
7. Kelley R.H., Baker W.H.: "Progestational agents in the treatment of carcinoma of the endometrium". N. Engl. J. Med., 1961, 264, 216.
8. Gitsch G., Hanzal E., Jensen D., Hacker N.F.: "Endometrial carcinoma in premenopausal women 45 years and younger". Obstet. Gynecol., 1985, 85, 804.
9. Saegusa M., Okayasu I.: "Progesterone therapy for endometrial carcinoma reduces cell proliferation but does not alter apoptosis". Cancer, 1998, 83, 111.
10. Ramirez P.T., Frumoritz M., Bodurka D.C., Sun C.C., Levenback C.: "Hormonal therapy for the management of grade 1 endometrial adenocarcinoma: a literature review". Gynecol. Oncol., 2004, 95, 133.
11. Larson D.M., Johnson K.K., Broste S.K., Krawisz B.R., Kresl J.J.: "Comparison of D&C and office endometrial biopsy in predicting final histopathologic grade in endometrial cancer". Obstet. Gynecol., 1995, 86, 34.
12. Ong S., Duffy T., Lenhan P., Murphy J.: "Endometrial pipelle biopsy compared to conventional dilatation and curettage". J. Med. Sci., 1997, 166, 47.
13. Bettocchi S., Ceci O., Vicino M., Marella F., Impedovo L., Selvaggi L.: "Diagnostic in adequacy of dilation and curettage". Fertil. Steril., 2001, 75, 803.
14. Stock R.G., Kanbour A.: "Prehysterectomy curettage". Obstet. Gynecol., 1975, 45, 537.
15. Varpula M.J., Klemi P.J.: "Staging of uterine endometrial carcinoma with ultra-low field (0.02 T) MRI: a comparative study with CT". J. Comput. Assist. Tomogr., 1993, 17, 641.
16. Zarbo G., Caruso G., Caruso S., Mangano U., Zarbo R.: "Endometrial cancer: prospective evaluation of myometrial infiltration magnetic resonance imaging versus transvaginal ultrasonography". Eur. J. Gynaecol. Oncol., 2000, 21, 95.
17. Podratz K.C., O'Brien P.C., Malkasian G.D. Jr., Decker D.G., Jefferies J.A., Edmonson J.H.: "Effects of progestational agents in treatment of endometrial carcinoma". Obstet. Gynecol., 1985, 66, 106.
18. Evans-Metcalf E.R., Brooks S.F., Reale F.R., Baker S.P.: "Profile of women 45 years of age and younger with endometrial cancer". Obstet. Gynecol., 1998, 91, 349.
19. Lai C.H., Hsueh S., Chao A.S., Soong Y.K.: "Successful pregnancy after tamoxifen and megestrol acetate therapy for endometrial carcinoma". Br. J. Obstet. Gynaecol., 1994, 101, 547.
20. Kaku T., Yoshikawa H., Tsuda H., Sakamoto A., Fukunaga M., Kuwabara Y. et al.: "Conservative therapy for adenocarcinoma and atypical endometrial hyperplasia of the endometrium in young women: central pathologic review and treatment outcome". Cancer Lett, 2001, 167, 39.
21. Gotlieb W.H., Beiner M.R., Shalmon B., Korach Y., Segal Y., Zmira N. et al.: "Outcome of fertility-sparing treatment with progestins in young patients with endometrial cancer". Obstet. Gynecol., 2003, 102, 718.
22. Dhar K.K., NeedhiRajan T., Koslowski M., Woolas R.P.: "Is levonorgestrel intrauterine system effective for treatment of early endometrial cancer? Report of four cases and review of the literature". Gynecol. Oncol., 2005, 97, 924.
23. Lowe M.P., Cooper B.C., Sood A.K., Davis W.A., Syrop C.H., Sorosky J.L.: "Implementation of assisted reproductive technologies following conservative management of FIGO grade I endometrial adenocarcinoma and/or complex hyperplasia with atypia". Gynecol. Oncol., 2003, 91, 569.